[ 9 ] Smith LJ, Fazzalari NL. The elastic fibre network of the human lumbar anulus fibrosus: architecture, mechanical function and potential role in the progression of intervertebral disc degeneration[J]. Eur Spine J, 2009, 18(4): 439-448.
[7]
Wang DL, Jiang SD, Dai LY. Biologic response of the intervertebral disc to static and dynamic compression in vitro[J]. Spine (Phila Pa 1976), 2007, 32(23): 2521-2528.
[8]
Hadjipavlou AG, Tzermiadianos MN, Bogduk N, et al. The pathophysiology of disc degeneration: a critical review[J]. J Bone Joint Surg Br, 2008, 90(10): 1261-1270.
[9]
Schumann B, Bolm-Audorff U, Bergmann A, et al. Lifestyle factors and lumbar disc disease: results of a German multi-center case-control study (EPILIFT)[J]. Arthritis Res Ther, 2010, 12(5): R193.
[10]
Goupille P, Mulleman D, Chevalier X. Is interleukin-1 a good target for therapeutic intervention in intervertebral disc degeneration: lessons from the osteoarthritic experience[J]. Arthritis Res Ther, 2007, 9(6): 110.
[11]
Solovieva S, Leino-Arjas P, Saarela J, et al. Possible association of interleukin 1 gene locus polymorphisms with low back pain[J]. Pain, 2004, 109(1-2): 8-19.
[12]
Thomas B, Thirion S, Humbert L, et al. Differentiation regulates interleukin-1beta-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase[J]. Biochem J, 2002, 362(Pt 2): 367-373.
[13]
Le M, Pockert A, Buttle DJ, et al. Matrix synthesis and degradation in human intervertebral disc degeneration[J]. Biochem Soc Trans, 2007, 35(Pt 4): 652-655.
Furusawa N, Baba H, Miyoshi N, et al. Herniation of cervical intervertebral disc: immunohistochemical examination and measurement of nitric oxide production[J]. Spine (Phila Pa 1976), 2001, 26(10): 1110-1116.
Abe Y, Akeda K, An HS, et al. Proinflammatory cytokines stimulate the expression of nerve growth factor by human intervertebral disc cells[J]. Spine (Phila Pa 1976), 2007, 32(6): 635-642.
Houpt JB, Mcmillan R, Wein C, et al. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee[J]. J Rheumatol, 1999, 26(11): 2423-2430.
[22]
Nakamura H, Shibakawa A, Tanaka M, et al. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis[J]. Clin Exp Rheumatol, 2004, 22(3): 293-299.
[23]
Walsh AJ, O’neill CW, Lotz JC. Glucosamine HCl alters production of inflammatory mediators by rat intervertebral disc cells in vitro[J]. Spine J, 2007, 7(5): 601-608.
[24]
Zhuang Y, Huang B, Li CQ, et al. Construction of tissue-engineered composite intervertebral disc and preliminary morphological and biochemical evaluation[J]. Biochem Biophys Res Commun, 2011, 407(2): 327-332.
[25]
Gatti JC. Glucosamine treatment for osteoarthritis[J]. Am Fam Physician, 2006, 73(7): 1189.
[26]
Liu W, Liu G, Pei F, et al. Kashin-Beck disease in Sichuan, China: report of a pilot open therapeutic trial[J]. J Clin Rheumatol, 2012, 18(1): 8-14.
[27]
Bruyere O, Pavelka K, Rovati LC, et al. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies[J]. Menopause, 2004, 11(2): 138-143.
[28]
Russell AL. Focusing on glucosamine sulfate[J]. Can Fam Physician, 2004, 50: 980-981.
Brisby H. Pathology and possible mechanisms of nervous system response to disc degeneration[J]. J Bone Joint Surg Am, 2006, 88(Suppl 2): 68-71.
[31]
Igarashi A, Kikuchi S, Konno S. Correlation between inflammatory cytokines released from the lumbar facet joint tissue and symptoms in degenerative lumbar spinal disorders[J]. J Orthop Sci, 2007, 12(2): 154-160.
[32]
Saal JS, Franson RC, Dobrow R, et al. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations[J]. Spine (Phila Pa 1976), 1990, 15(7): 674-678.
Le Maitre CL, Freemont AJ, Hoyland JA. The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration[J]. Arthritis Res Ther, 2005, 7(4): R732-R745.
[35]
Lotz JC, Ulrich JA. Innervation, inflammation, and hypermobility May characterize pathologic disc degeneration: review of animal model data[J]. J Bone Joint Surg Am, 2006, 88(Suppl 2): 76-82.
[36]
Henrotin Y, Mobasheri A, Marty M. Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis[J]. Arthritis Res Ther, 2012, 14(1): 201.
